Zöller B, Engel H J, Faust-Tinnefeldt G, Geissler H E, Gilfrich H J, Zimmer M
Eur J Rheumatol Inflamm. 1982;5(2):82-6.
The influence of maintenance therapy with benoxaprofen, 600 mg daily, on digoxin steady-state plasma levels was studied in 12 patients with rheumatic disease. No difference could be shown during concomitant therapy or after withdrawal of benoxaprofen (p greater than 0.10 and p greater than 0.90, respectively). Toxic concentrations were not observed. There were no changes in renal function values.
对12例风湿性疾病患者研究了每日600毫克苯恶洛芬维持疗法对地高辛稳态血药浓度的影响。在联合治疗期间或停用苯恶洛芬后均未显示出差异（分别为p>0.10和p>0.90）。未观察到中毒浓度。肾功能值无变化。
